Stem Cells, Vol 11, 455-464, Copyright © 1993 by AlphaMed Press

ORIGINAL ARTICLES

The tetrapeptide AcSerAspLysPro (Seraspenide), a hematopoietic inhibitor, may reduce the in vitro toxicity of 3'-azido-3'- deoxythymidine to human hematopoietic progenitors

C Grillon, D Bonnet, JY Mary, M Lenfant, A Najman and M Guigon
Institut de Chimie des Substances Naturelles, CNRS, Gif sur Yvette, France.

3'-azido-3'-deoxythymidine (AZT), the main antiviral drug used in AIDS treatment, is known to induce anemia and neutropenia. These effects have been attributed to its toxicity to hematopoietic progenitors. In this report, we present a new approach to reduce AZT hematotoxicity by using an inhibitory factor of the hematopoietic stem cells, the tetrapeptide AcSerAspLysPro (AcSDKP, Seraspenide), which has been shown to increase the survival of mice subjected to high doses of chemotherapy and to block reversibly the cycling of human granulocyte- macrophage colony forming unit (CFU-GM) and burst forming unit erythroid (BFU-E) progenitors. Normal bone marrow mononuclear cells (BMMNC) from 14 subjects were incubated with or without AcSDKP (10(-10) M) for 20 h and with or without AZT (100 microM) for another 2 h. After washing, cells were plated in methylcellulose in the presence of interleukin 3 (IL-3), granulocyte-macrophage colony stimulating factor (GM-CSF) and erythropoietin (EPO). Under these conditions, the preincubation of cells with AcSDKP reduced significantly the toxicity of AZT to both BFU-E and CFU-GM at least in 3 out of 8 and 4 out of 10 cases, respectively. A careful statistical analysis of these observations indicates that AcSDKP may be an efficient factor in preserving progenitors against AZT-induced hematopoietic toxicity.

This article has been cited by other articles:

				N.-E. Rhaleb, H. Peng, X.-P. Yang, Y.-H. Liu, D. Mehta, E. Ezan, and O. A. Carretero Long-Term Effect of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline on Left Ventricular Collagen Deposition in Rats With 2-Kidney, 1-Clip Hypertension Circulation, June 26, 2001; 103(25): 3136 - 3141. [Abstract] [Full Text] [PDF]

				S. Gaudron, C. Grillon, J. Thierry, A. Riches, P. K. Wierenga, and J. Wdzieczak-Bakala In Vitro Effect of Acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) Analogs Resistant to Angiotensin I-Converting Enzyme on Hematopoietic Stem Cell and Progenitor Cell Proliferation Stem Cells, March 1, 1999; 17(2): 100 - 106. [Abstract] [Full Text]

				D. Hajek, H. Kubesova, R. Vyzula, J. Mayer, M. Druckmueller, M. Tomiska, and A. Vasku Bone Marrow as Multidimensional Orbit Oscillator after Autologous Bone Marrow Transplantation Stem Cells, January 1, 1999; 17(1): 25 - 30. [Abstract] [Full Text]

				A. Masse, L.H. Ramirez, G. Bindoula, C. Grillon, J. Wdzieczak-Bakala, K. Raddassi, E. Deschamps de Paillette, J.M. Mencia-Huerta, S. Koscielny, P. Potier, et al. The Tetrapeptide Acetyl-N-Ser-Asp-Lys-Pro (Goralatide) Protects From Doxorubicin-Induced Toxicity: Improvement in Mice Survival and Protection of Bone Marrow Stem Cells and Progenitors Blood, January 15, 1998; 91(2): 441 - 449. [Abstract] [Full Text] [PDF]